Surveillance for rotavirus in Argentina

Journal of Medical Virology

Volumn 65, Issue 1, 2001, Pages 190-198

  Bok, Karin ^a   Castagnaro, Nelda ^b   Borsa, Ana ^c   Nates, Silvia ^d   Espul, Carlos ^e   Fay, Oscar ^f   Fabri, Adriana ^g   Grinstein, Saul ^h   Miceli, Isabel ⁱ   Matson, David O ^j   Gómez, Jorge A ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^b UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

^c Hospital de Ninos Sor Maria Ludovica   (Argentina)

^d FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^e Hospital Central Mendoza   (Argentina)

^f Public Health Technology Center   (Argentina)

^g Regional Institute of Medicine   (Argentina)

^h Children's Hospital   (Argentina)

ⁱ Ministerio de Salud de la Nación   (Argentina)

^j CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

more..

Author keywords

Epidemiology; Genotypes; Rotavirus; Serotype; VP4; VP7

Indexed keywords

ARGENTINA; ARTICLE; GENOTYPE; HEALTH SURVEY; HUMAN; NONHUMAN; PREVALENCE; ROTAVIRUS; SEROTYPE; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD; VIRUS TYPING;

AGE DISTRIBUTION; ARGENTINA; CHILD, PRESCHOOL; DIARRHEA; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; POPULATION SURVEILLANCE; ROTAVIRUS; ROTAVIRUS INFECTIONS; SEASONS; SEROTYPING;

EID: 0034903980     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.2020     Document Type: Article

References (45)

1. VP7 and VP4 genotyping of human group A rotavirus in Buenos Aires, Argentina
2. Protection from rotavirus reinfection: 2-Year prospective study
3. Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: A randomised placebo-controlled trial
4. Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea
5. Use of serotype-specific monoclonal antibodies to study the epidemiology of rotavirus infection
6. Development of candidate rotavirus vaccines
7. G and P genotyping of rotavirus strains circulating in France over a three-year period: Detection of G9 and P[6] strains at low frequencies
8. Variación temporal de electroferotipos y serotipos de rotavirus humanos en el noroeste Argentino
9. Intussusception among recipients of rotavirus vaccine - United States, 1998-1999
10. Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants
11. Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype
12. Simple and specific enzyme immunoassay using monoclonal antibodies for serotyping human rotaviruses
13. Characterisation of rotaviruses from children treated at a London hospital during 1996: Emergence of strains G9P2A[6] and G3P2A[6]
14. Characterization of rotavirus strains from newborns in New Delhi, India
15. Interventions for the control of diarrhoeal diseases among young children: Rotavirus and cholera immunization
16. Location of major antigenic sites involved in rotavirus serotype-specific neutralization
17. Characterization of antigenic types of circulating rotaviruses in Mendoza, Argentina based on typing of the external VP7 capsid protein
18. Identification of group A rotavirus gene 4 types by polymerase chain reaction
19. Review of G and P typing results from a global collection of rotavirus strains: Implications for vaccine development
20. Estimates of the morbidity and mortality from diarrheal diseases in American children
21. The epidemiology of rotavirus diarrhea in the United States: Surveillance and estimates of disease burden
22. Rotavirus vaccines at the threshold
23. Serotyping of human rotaviruses in Argentina by ELISA with monoclonal antibodies
24. Anticipating rotavirus vaccines: Review of epidemiologic studies of rotavirus diarrhea in Argentina
25. Rotavirus diarrhea: Impact in a pediatric hospital of Buenos Aires
26. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens
27. Prediction of human rotavirus serotype by nucleotide sequence analysis of the VP7 protein gene
28. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccines: Implications for vaccine development
29. Surveillance of rotavirus strains in the United States: Identification of unusual strains
30. Rotavirus as a cause of diarrheal morbidity and mortality in the United States
31. Comparison of specific and random priming in the reverse transcriptase polymerase chain reaction for genotyping group A rotaviruses
32. Diversity within the VP4 gene of rotavirus P[8] strains: Implications for reverse transcription-PCR genotyping
33. Characterization of homotyping and heterotypic VP7 neutralization sites of rhesus rotavirus
34. Serotype variation of human group A rotaviruses in two regions of the USA
35. Emergence of serotype G9 human rotaviruses in Australia
36. Rotavirus
37. Unusual diversity of human rotavirus G and P genotypes in India
38. Detection and characterization of novel rotavirus strains in the United States
39. DNA sequencing with chain-terminating inhibitors
40. Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3
41. Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4- specific monoclonal antibodies to VP7
42. Visualizing geographic and temporal trends in rotavirus activity in the United States, 1991 to 1996
43. Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: Emergence of type G9 in 1995
44. Rotavirus infections in infants as protection against subsequent infections
45. Protection against rotavirus disease after natural rotavirus infection